HealthInvest Partners AB is an institution, managing $25.6M across 36 long positions as of Q3 2025 with 97% Healthcare concentration and 56% concentrated in top 10 holdings.
Largest long holdings in HealthInvest Partners AB's portfolio (56% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Drug Manufacturers - General Healthcare | $3.0M | 11.80% | -$119.6K Sold | 0.00% 37.2K shares | |
Drug Manufacturers - General Healthcare | $2.3M | 8.85% | +$127.1K Bought | 0.01% 92.1K shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $1.5M | 5.98% | +$212.1K Bought | 0.10% 102.6K shares | |
Drug Manufacturers - General Healthcare | $1.4M | 5.61% | +$193.7K Bought | 0.01% 160.9K shares | |
Medical - Diagnostics & Research Healthcare | $1.4M | 5.47% | +$148.3K Bought | 0.01% 27.1K shares | |
Biotechnology Healthcare | $963.4K | 3.77% | +$51.0K Bought | 0.09% 174.7K shares | |
Medical - Distribution Healthcare | $949.2K | 3.71% | -$94.8K Sold | — 28.6K shares | |
Medical - Instruments & Supplies Healthcare | $935.7K | 3.66% | +$54.5K Bought | 0.01% 19.7K shares | |
Drug Manufacturers - General Healthcare | $921.2K | 3.60% | +$59.0K Bought | 0.01% 78.2K shares | |
Medical - Devices Healthcare | $898.4K | 3.51% | -$409.5K Sold | 0.01% 86.7K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in HealthInvest Partners AB's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
+109.3% | |
+85.34% | |
+48.42% |
| Position | Shares Δ |
|---|---|
Sold | |
-42.22% | |
-31.31% | |
-26.97% | |
-19.85% |
Portfolio insights and performance metrics for HealthInvest Partners AB
We use cookies for analytics. See our Privacy and Cookie Policy.